alleging they illegally drove up drug prices. Apart from pharmacy benefit managers, the FTC says Eli Lilly, Sanofi and Novo Nordisk have control over the insulin market, and all three companies ...

In its complaint, the FTC alleges that PBMs followed a “chase-the-rebate strategy,” which led to soaring insulin list prices and made it harder for Americans to get the crucial medication ...

(AP) - The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin ... the drug prices. The FTC said the ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

(AP) - The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic ... and negotiate rebates ...